Cargando…
SUN-587 Oral Liothyronine (LT3) May Be Better Absorbed Compared to LT4 Tablets after Biliopancreatic Diversion Surgery
Introduction: Levothyroxine (LT4) is the mainstay of treating hypothyroidism patients. Increased levothyroxine requirements are expected after bariatric surgery and small bowel diseases. There have been studies showing treatment of resistant hypothyroidism following bariatric surgery with soft gel o...
Autores principales: | El-Zein, Louna, Chaker, Bayan, Alim, Hussam, Taha, Wael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553176/ http://dx.doi.org/10.1210/js.2019-SUN-587 |
Ejemplares similares
-
SAT-507 Myxedema Coma: A Fatal Diagnosis in a Patient with No Known History of Hypothyroidism
por: Chaker, Bayan, et al.
Publicado: (2020) -
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020) -
SUN-581 An Unusual Presentation of Hypothyroidism
por: Alim, Hussam, et al.
Publicado: (2019) -
Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design
por: Premawardhana, Lakdasa D., et al.
Publicado: (2023) -
SUN-550 Pressor Refractory, Liothyronine Responsive Myxedema Cardiogenic Shock without Myxedema Coma
por: Willis, Cornelia, et al.
Publicado: (2019)